-
Kenya's economy faces climate change risks: World Bank
-
Commerzbank agrees to talks with UniCredit after two-year standoff
-
Profits surge at US oil giant amid Iran war supply shock
-
Fornaro Legal Releases Guidance to Help Businesses Maintain Clear Ownership Records During Growth
-
Stock markets rally on tech rebound
-
Japan probe made closest-ever asteroid flyby: space agency
-
France, Spain assess scorched terrain as new wildfires threaten other regions
-
British oil giant BP aims to sell North Sea business
-
Chipmaker Kioxia reports AI-driven 45-fold surge in quarterly net profit
-
China factory activity slides as leaders seek spending boost
-
Far right and far left battle for power in polarised Berlin
-
Tech rebound fuels record-breaking rally in South Korean stocks
-
The last trio: S.Africa's zoo elephants await their fate
-
Cables and cooling bring AI windfall to Indian suppliers
-
Oil industry sees war windfall but girds for political blowback
-
Anthropic's models gained unauthorized 'real-world' access during testing
-
Amazon beats expectations with cloud and AI growth
-
Apple tops estimates in CEO Cook's final quarter, but shares fall
-
Blowout Microsoft results lift US stocks as oil retreats
-
Milei demands expulsion of foreigners expressing 'hate' against Argentina
-
'Beginning of the end': Relief but no party as French wildfire winds down
-
Italy's Po River valley on drought alert
-
Southern Europe 'becoming more flammable' in hotter climate, experts say
-
Prada profits pinched as growth hard to chase
-
Mammoth bones found on parched bed of Danube in Bulgaria
-
Stocks climb on earnings and rates, oil retreats
-
MEXC Lists Grvt (GRVT) with $60,000 Worth of GRVT and 10,000 USDT in Airdrop+ Rewards
-
US economic growth slows in second quarter, missing expectations
-
George and Amal Clooney flee French home due to wildfire
-
Russia adds Telegram founder Durov to 'terrorist' blacklist
-
MEXC Ventures Supports Alpha Arena's APAC Debut at Coinfest Bali
-
Stocks diverge on earnings, as oil steadies
-
AI data centre supplier Zhongji InnoLight slips on Hong Kong debut
-
Eurozone economy grows despite Middle East war
-
May, June heatwaves caused 2,877 extra deaths in England: govt
-
Singapore group will develop 'most promising' Ebola vaccine
-
BMW profit down a third as carmaker plans job cuts
-
Shell profit surges as Mideast war fuels oil prices
-
Seoul extends losses as most Asian markets drop, oil rises again
-
Car maker Stellantis says back in profit in second quarter
-
Gambling.com Group Is Now Grandstand
-
Samsung quarterly operating profit up 1,800% on AI boom
-
Meet the astronomer digging into the Milky Way's 'fossils'
-
South Korean stocks bounce after rout, oil holds gains on Mideast woes
-
AI data centre supplier Zhongji InnoLight falls on Hong Kong debut
-
South Korea's women web sleuths fight AI deepfake porn
-
Samsung operating profit up 1,800% in second quarter on AI boom
-
Anything but programmable: New cost-efficient EC-power-supply-series for the DIN rail by CAMTEC PS
-
Japanese population below 120 million for first time in decades
-
Meta misses profit expectations, sticks to massive AI spending
Scientists grow human-like kidneys in pigs
Chinese scientists have succeeded in growing kidneys containing human cells in pig embryos, a world first that could one day help address organ donation shortages.
But the finding, published in a study in the journal Cell Stem Cell on Thursday, raises ethical issues -- especially since some human cells were also found in the pigs' brains, experts said.
The researchers from the Guangzhou Institutes of Biomedicine and Health focused on kidneys because they are on the first organs to develop, and the most commonly transplanted in human medicine.
"Rat organs have been produced in mice, and mouse organs have been produced in rats, but previous attempts to grow human organs in pigs have not succeeded," senior author Liangxue Lai said in a statement.
"Our approach improves the integration of human cells into recipient tissues and allows us to grow human organs in pigs."
This is a different approach to the recent high-profile breakthroughs in the United States, where genetically modified pig kidneys and even a heart have been placed inside humans.
The new paper "describes pioneering steps in a new approach to organ bioengineering using pigs as incubators for growing and cultivating human organs," said Dusko Ilic, a professor of stem cell sciences at King's College London who was not involved in the research.
Ilic cautioned there would be many challenges to turning the experiment into a viable solution, but "nevertheless, this captivating strategy warrants further exploration."
- Gene editing -
A major challenge in creating such hybrids has been that pig cells outcompete human cells.
To overcome the obstacles, the team used CRISPR gene editing to delete two genes essential for kidneys to form inside a pig embryo, creating what's called a "niche."
They then added specially prepared human pluripotent stem cells -- cells that have the potential to develop into any cell type -- which filled the niche.
Before implanting the embryos in sows, they grew them in test tubes containing substances that nourished both the human and pig cells.
In total, they transferred 1,820 embryos into 13 surrogate mothers. The pregnancies were terminated at 25 and 28 days to assess how the experiment had worked.
Five embryos selected for analysis were found to have functionally normal kidneys for their stage of development. They contained between 50 and 60 percent human cells.
"We found that if you create a niche in the pig embryo, then the human cells naturally go into these spaces," said co-author Zhen Dai.
"We saw only very few human neural cells in the brain and spinal cord and no human cells in the genital ridge."
But the presence of any human cells in the pig brains raises concerns, said Darius Widera, a professor of stem cell biology at the University of Reading.
"Although this approach is a clear milestone and the first successful attempt to grow whole organs containing human cells in pigs, the proportion of human cells in the generated kidneys is still not high enough," he added.
In the long run, the team wants to optimize their technology for use in human transplantation, but admits it's not ready yet.
An important limitation was the kidneys had pig-derived vascular cells, which could cause rejection if transplanted into a human.
Nevertheless, the team is already working on growing other human organs in pigs such as the heart and pancreas.
O.Ignatyev--CPN